A Patient Prospector Logomark

Field Notes for Investors.

Patient research. Enduring Value.

Independent ideas for investors who think beyond the next quarter.

Independent. Rigorous. Long-Term.

A Patient Prospector Logomark

STOCK RESEARCH

From weekly commentary and monthly newsletters to in-depth insights and timely action alerts, we help long-term investors gain the clarity and conviction needed to navigate the markets with confidence.

the prudent speculator,a patient prospector,john buckingham,value newsletter

Weekly

Goal Prices

Weekly updates to our Goal Price list keep you current with changing fundamentals, market conditions, and new information, helping you make more informed decisions.

the prudent speculator,a patient prospector,john buckingham,value newsletter

Mondays

Market Observations

Each week, we write about market conditions, economic indicators and important individual stock developments to help investors understand what they may mean for their investments.

the prudent speculator,a patient prospector,john buckingham,value newsletter

Monthly

Newsletter

Each month, we look beyond the headlines to review market developments, explore important themes, share portfolio ideas and examine individual stocks.

the prudent speculator,a patient prospector,john buckingham,value newsletter

Quarterly

Insights & Reports

In-depth research and timely perspectives on a range of investment topics, including factor research and stock analysis.

the prudent speculator,a patient prospector,john buckingham,value newsletter

"The stock market is a device for transferring money from the impatient to the patient."

- Warren Buffett

November 2, 2026

Market Observations for November 2, 2026

“It was déjà vu all over again,” to quote Yogi Berra, as the final trading week of October was a rerun of the week prior, with the lead for Value […] Continue Reading...

October 26, 2026

Market Observations for October 26, 2026

With the lead for Value over Growth since Halloween 2025 widening last week, we were again reminded that it is a market of stocks and not simply a stock market. […] Continue Reading...

October 19, 2026

Market Observations for October 19, 2026

Understanding that anything can happen in the financial markets as we move forward and that the financial press exists to attract eyeballs, The Wall Street Journal strikes again! With U.S. […] Continue Reading...

A Patient Prospector Logomark

SERVING DIY INVESTORS

We are different.

We have decades of experience taking a disciplined, long-term approach to investing, combining our own rigorous research with practical insights designed to help individual investors act with clarity and conviction.

app who we are
Who We Are

We are an independent investment publication focused on decision-useful research, fundamental number-crunching and qualitative analysis in the pursuit of unearthing undervalued stocks.

app who we serve
Who We Serve

We serve individual and institutional investors who think in years and value independent judgment, helping them make informed decisions without being distracted by market noise.

app differentiation
Differentiation

We distinguish ourselves through a disciplined Value-investing framework, rigorous fundamental research and a willingness to maintain our long-term view when market headwinds blow.

A Patient Prospector Logomark

From the Editor

"We are not in the business of predicting the market. We are in the business of finding stocks worth owning and holding them for the fullness of time."

John Buckingham
Editor - A Patient Prospector

A Patient Prospector Logomark

INSIGHTS & SPECIAL REPORTS

Deep dives with conviction.

We write in-depth market insights and special reports for investors seeking thoughtful perspectives and actionable ideas for their portfolios. Our research helps readers identify opportunities across the market while maintaining a steady, long-term perspective.

November 3, 2026

Issue #2

November 2, 2026

Market Observations for November 2, 2026

“It was déjà vu all over again,” to quote Yogi Berra, as the final trading week of October was a rerun of the week prior, with the lead for Value […] Continue Reading...

October 29, 2026

Sales Alert for October 29, 2026

We always endeavor to be patient in our prospecting, but there eventually comes a time when we think it best to abandon an unproductive claim so that resources can be […] Continue Reading...

A Patient Prospector Logomark

Research Access

Depth of research, matched to your commitment.

Whether you’re exploring our work or ready to make it part of your investing process, choose the level of access that fits your interests and commitment. Every plan offers independent research built in support of individual investors.

Level I

Free

Surface-level research access. The commentary, delivered weekly.

$0 / Month

  • N
    Weekly Market Observations (excludes individual stock analysis)
  • N
    Monthly Newsletter Editor's Note
  • N
    Special Report & Insight Previews
  • N
    Webinars

Level II

Premium

The complete analytical record. Rigorous research, without the noise.

$8 / Month

  • N
    Weekly Market Observations + Individual Stock Analysis
  • N
    Monthly Newsletter Editor's Note
  • N
    Special Report & Insight Previews
  • N
    Webinars

Level III

All Access

Portfolio-grade intelligence. The complete research experience.

$39 / Month

  • N
    Weekly Goal Price List
  • N
    Weekly Market Observations + Individual Stock Analysis
  • N
    Buy & Sell Action Alerts
  • N
    Monthly Newsletter
  • N
    Special Reports
  • N
    Investment Insights
  • N
    Premium Webinars

Save With Annual Billing!

Subscription fees shown above apply only to A Patient Prospector research and publication services. Investment advisory services are offered through MPS, an SEC-registered investment adviser, pursuant to a separate advisory agreement and are subject to advisory fees separate from any applicable A Patient Prospector subscription fees.

A Patient Prospector Logomark

The Editor-in-Chief

the prudent speculator,a patient prospector,john buckingham,value newsletter

John Buckingham

  • Editor - A Patient Prospector
  • Co-Founder - Value87 Investment Partners

For nearly 40 years, John Buckingham has applied the value-investing discipline inspired by Al Frank, Benjamin Graham and Warren Buffett. His investment experience spans countless market cycles and reflects the patience required to remain invested through them all.

He previously served as Chief Investment Officer of AFAM Capital and as Editor of The Prudent Speculator. John co-founded A Patient Prospector as an independent research platform, allowing him to focus on long-term investing without constraints.

His philosophy is deceptively simple: buy quality businesses at reasonable prices and hold them for the fullness of time.

Learn about John and the team behind A Patient Prospector.